Cytokinetics Inc’s recently made public that its Director EDWARD KAYE acquired Company’s shares for reported $0.12 million on Jun 05 ’25. In the deal valued at $32.41 per share,3,636 shares were bought.
Then, Kaye Edward M. MD sold 3,636 shares, generating $116,716 in total proceeds. Upon selling the shares at $32.10, the Director now owns 29,658 shares.
Before that, Callos Andrew sold 8,659 shares. Cytokinetics Inc shares valued at $277,434 were divested by the EVP, Chief Commercial Officer at a price of $32.04 per share. As a result of the transaction, Callos Andrew now holds 52,028 shares, worth roughly $1.79 million.
Barclays initiated its Cytokinetics Inc [CYTK] rating to an Overweight in a research note published on April 24, 2025; the price target was $55. A number of analysts have revised their coverage, including Citigroup’s analysts, who began to cover the stock in early February with a ‘”a Buy”‘ rating. Stifel began covering CYTK with “Buy” recommendation on January 22, 2025. RBC Capital Mkts started covering the stock on November 08, 2024. It rated CYTK as “an Outperform”.
Price Performance Review of CYTK
On Friday, Cytokinetics Inc [NASDAQ:CYTK] saw its stock jump 3.55% to $34.38. Over the last five days, the stock has gained 6.44%. Cytokinetics Inc shares have fallen nearly -26.91% since the year began. Nevertheless, the stocks have fallen -35.49% over the past one year. While a 52-week high of $61.38 was reached on 01/27/25, a 52-week low of $29.31 was recorded on 05/15/25.
Levels Of Support And Resistance For CYTK Stock
The 24-hour chart illustrates a support level at 33.21, which if violated will result in even more drops to 32.04. On the upside, there is a resistance level at 34.98. A further resistance level may holdings at 35.58.
How much short interest is there in Cytokinetics Inc?
A steep rise in short interest was recorded in Cytokinetics Inc stocks on 2025-05-30, growing by 18384.0 shares to a total of 14.5 million shares. Yahoo Finance data shows the prior-month short interest on 2025-04-30 was 14.48 million shares. There was a rise of 0.13%, which implies that there is a positive sentiment for the stock.
